Drug discovery

#BioIVT #Cancer research #Drug development #Drug discovery #iOnctura #Kazia Therapeutics #Sartorius #Vyriad Therapeutics #Webinar

Last chance to register: Drug discovery challenges in cancer research

Hosted by Drug Discovery World and supported by Sartorius and BioIVT, this webinar will explore the opportunities and challenges that exist within cancer research drug discovery and development. You will hear from Dr Sudha Rao, Chief Scientific Officer of Kazia Therapeutics, Karol Budzik, PhD, Business Development Associate at Vyriad Therapeutics… Read More

#News

#Drug discovery #Genetics #Genomics #Target discovery

From disease genetics to more effective medicines 

Dr James Heward, VP Functional Genomics at Nucleome Therapeutics, discusses what could be the missing link in the chain of causality from patient to target to drug.   The fundamental question that stalks every drug discovery project is “will this drug fail?” Most do. There is no single reason for more than 90% of clinical trials… Read More

#Exclusive Content

Microplate
#App note #Drug discovery #High throughput screening #Liquid handling

App Note: Advancing biophysical ultra high-throughput screening

A new resource is now available to download for free. Efficient assay preparation and reliable affinity measurements are critical to successful screening campaigns. This technical note explores how Dianthus uHTS can be integrated with Echo Acoustic Liquid Handling to support automated, miniaturised affinity screening workflows. Download the App Note to… Read More

#News

#BioIVT #Cancer research #Drug development #Drug discovery #iOnctura #Kazia Therapeutics #Sartorius #Vyriad Therapeutics #Webinar

Webinar explores drug discovery challenges in cancer research

Hosted by Drug Discovery World and supported by Sartorius and BioIVT, this webinar will explore the opportunities and challenges that exist within cancer research drug discovery and development. You will hear from Dr Sudha Rao, Chief Scientific Officer of Kazia Therapeutics, Karol Budzik, PhD, Business Development Associate at Vyriad Therapeutics… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (14-18 September 2026) 

News round-up for 14-18 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Digital Forum and the Drug Discovery Innovators & Investors Conference in London, changes to US scientific research grant screening, the UK’s… Read More

#News

US science protest
#Drug discovery #Funding #National Institutes of Health (NIH) #Politics #United States

Researchers challenge NIH screening of scientific research grants

US researchers have filed a class action lawsuit challenging the National Institutes of Health’s (NIH) policy of blocking grants to censor views it disagrees with, on everything from DEI to gender identity to climate change.  The plaintiffs are represented by the American Civil Liberties Union, the ACLU… Read More

#Editor's Choice #News #Trending News

#DDII #DDIIDigitalForum #DDIIeventseries #Drug discovery #Drug discovery events #Drug Discovery Innovators & Investors #Events

Less than two weeks until Drug Discovery Innovators & Investors Digital Forum

Experts from across the drug discovery ecosystem will explore the technologies, strategies, therapies and investment trends shaping early-stage drug discovery at the Drug Discovery Innovators & Investors (DDII) Digital Forum on 30 September. The Forum is free to attend. Register for the full event, or simply join one of the… Read More

#Editor's Choice #News

Cancer cells
#BioIVT #Cancer research #Drug development #Drug discovery #iOnctura #Kazia Therapeutics #Sartorius #Vyriad Therapeutics #Webinar

Drug discovery challenges in cancer research webinar

Hosted by Drug Discovery World and supported by Sartorius and BioIVT, this webinar will explore the opportunities and challenges that exist within cancer research drug discovery and development. You will hear from Karol Budzik, PhD, Business Development Associate at Vyriad Therapeutics and Lars van der Veen, Chief Scientific Officer at… Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #Infectious diseases #Lab automation #Organoids #UK

New robotic AI lab opens in Liverpool to help fight infectious diseases  

The UK’s first high-security robotic AI laboratory designed to accelerate the discovery of drugs and vaccines for infectious diseases has opened in Liverpool.   The £20 million Liverpool Accelerate Laboratory has been developed through the Infection Innovation Consortium: iiCON, which advances pioneering infection R&D through collaboration between industry, researchers and the NHS. It… Read More

#News

#Automation #Chromatography #Drug discovery #Purification technology #Webinar

Last chance to register: Rethinking protein purification

Join this webinar, hosted by DDW and supported by Cytiva, to learn how automation, parallel chromatography, and smart software features can help scientists increase throughput, reduce hands-on time, and maintain consistent purification performance. Join for free on Tuesday, September 15 to learn: How parallel chromatography can be used to process… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (7-11 September 2026) 

News round-up for 7-11 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers upcoming Drug Discovery Innovators & Investors (DDII) in-person events and forum updates, alongside the latest Phase II clinical data across coeliac disease, bronchiectasis and head and neck cancer. Read More

#News

#DDII #DDIIDigitalForum #DDIIeventseries #Drug discovery #Drug discovery events #Drug Discovery Innovators & Investors #Events

Drug Discovery Innovators & Investors Digital Forum offers certificate of attendance

Join us on 30 September for the Drug Discovery Innovators & Investors (DDII) Digital Forum, where experts from across the drug discovery ecosystem explore the technologies, strategies, therapies and investment trends shaping early-stage drug discovery. The Forum is free to attend. Register for the full event, or simply join one… Read More

#News